CD274 and pancreatic ductal adenocarcinoma: For example, in pancreatic ductal adenocarcinoma, PD-L1 blockade therapy is usually ineffective, but the addition of the WNT inhibitor LGK974 allows PD-L1 blockade therapy to exert an inhibitory effect on the growth of pancreatic cancer.